insulin sensitizers - PPAR modulator

TrialStudied treatmentControl treatmentpatientsROBResultNCT

diabetes type 2

aleglitazar
ALECARDIOaleglitazarplacebo - NCT01042769
BC22140 ongoing aleglitazarplacebo - NCT01042769
BC20265 ongoing aleglitazaractos - NCT00461058